Table 1.
Characteristics of patients with end-stage renal disease according to NSAID use
| Characteristics | Total | Any NSAID use | P-value | ||||
|---|---|---|---|---|---|---|---|
| (N=3,383) | Yes (N=2,623) | No (N=760) | |||||
| N (%) | N (%) | N (%) | |||||
| Age, years | <0.001 | ||||||
| <55 | 1,088 | (32.2) | 926 | (35.3) | 162 | (21.3) | |
| 55–64 | 816 | (24.1) | 654 | (24.9) | 162 | (21.3) | |
| 65–74 | 809 | (23.9) | 625 | (23.8) | 184 | (24.2) | |
| ≥75 | 670 | (19.8) | 418 | (15.9) | 252 | (33.2) | |
| Sex | 0.91 | ||||||
| Male | 1,720 | (50.8) | 1335 | (50.9) | 385 | (50.7) | |
| Female | 1,663 | (49.2) | 1288 | (49.1) | 375 | (49.3) | |
| Residence area | 0.18 | ||||||
| Central city | 1,893 | (56.0) | 1486 | (56.7) | 407 | (53.6) | |
| Suburban | 1,091 | (32.3) | 840 | (32.0) | 251 | (33.0) | |
| Countryside | 399 | (11.8) | 297 | (11.3) | 102 | (13.4) | |
| Dialysis | 0.60 | ||||||
| Hemodialysis | 3,082 | (91.1) | 2386 | (91.0) | 696 | (91.6) | |
| Peritoneal dialysis | 301 | (8.9) | 237 | (9.0) | 64 | (8.4) | |
| Comorbidity | |||||||
| Myocardial infarction | 151 | (4.5) | 96 | (3.7) | 55 | (7.2) | <0.001 |
| Congestive heart failure | 842 | (24.9) | 583 | (22.2) | 259 | (34.1) | <0.001 |
| Peripheral vascular disease | 66 | (2.0) | 48 | (1.8) | 18 | (2.4) | 0.35 |
| Cerebrovascular disease | 495 | (14.6) | 314 | (12.0) | 181 | (23.8) | <0.001 |
| Chronic pulmonary disease | 381 | (11.3) | 283 | (10.8) | 98 | (1.9) | 0.11 |
| Liver disease | 210 | (6.2) | 161 | (6.1) | 49 | (6.5) | 0.76 |
| Dementia | 88 | (2.6) | 43 | (1.6) | 45 | (5.9) | <0.001 |
| Rheumatoid disease | 50 | (1.5) | 40 | (1.5) | 10 | (1.3) | 0.67 |
| Peptic ulcer | 704 | (20.8) | 529 | (20.2) | 175 | (23.0) | 0.09 |
| Hypertension | 2,906 | (85.9) | 2236 | (85.3) | 670 | (88.2) | 0.04 |
| Diabetes mellitus | 1,824 | (53.9) | 1357 | (51.7) | 467 | (61.5) | <0.001 |
| Opioid use | 1,385 | (40.9) | 1240 | (47.3) | 145 | (19.1) | <0.001 |